E-Paper
Sign In
UAE's first brain chip trials to be held in Abu Dhabi with Neuralink
The trial, known as UAE-PRIME, will explore how people with motor and speech impairment can use thought to control devices and communicate
- PUBLISHED: Fri 16 May 2025, 8:47 PM
Elon Musk's Neuralink has announced that it is launching its first clinical trial in the region in Abu Dhabi.
Partnering with Abu Dhabi's Department of Health and Cleveland Clinic, the trial, known as UAE-PRIME, will explore how people with motor and speech impairment can use thought to control devices and communicate.
Recommended For You
Neuralink is a company that develops advanced brain-computer interface (BCI) systems connecting the human brain directly to computers by implanting a chip in the brain.
Stay up to date with the latest news. Follow KT on WhatsApp Channels.
In an announcement, Neuralink said that "this is an important step towards making our groundbreaking technology available worldwide to transform the lives of millions affected by debilitating neurological conditions."
Mansoor Al Mansoori, the Chairman of the Department of Health has said that the trial "marks an important step in advancing brain computer interface technology on a global scale".
He added: "In partnership with Cleveland Clinic Abu Dhabi, we are proud to support innovation that is grounded in ethics, driven by science, and focused on restoring hope for patients around the world."
How does this study work?
Participants will first undergo a surgery in which a robot will plant a chip (N1) into a part of the brain that controls movement intention.
The device will then record neural activity and allow users to control a computer through the N1 user app.
This study will span approximately six years and will begin with an 18-month primary phase, which will be followed by five years of long-term follow up.
Who is eligible?
Neuralink has outlined eligibility for the study in a brochure on its website. Here's the criteria, the applicant must:
1. Have quadriplegia (limited function in all 4 limbs) due to:
Spinal cord injury, or
Amyotrophic lateral sclerosis (ALS)
2. Be at least 1 year post-injury without improvement
3. Be 22 years old or older
4. Have a consistent and reliable caregiver